Seeking Alpha

Optimer Pharmaceuticals (OPTR) surges 18.1% following a report that the antibiotics maker has...

Optimer Pharmaceuticals (OPTR) surges 18.1% following a report that the antibiotics maker has attracted takeover interest from GlaxoSmithKline (GSK), AstraZeneca (AZN), Cubist Pharmaceuticals (CBST) and Japan's Astellas. Optimer hopes to fetch up to $1B in an auction, well above its market cap of $660M. The company has one drug on the market, Dificid, which is used to treat intestinal infections in hospitalized patients.
Comments (1)
  • Michael Bryant
    , contributor
    Comments (5911) | Send Message
     
    That would be about $19.51 / share of (OPTR). I doubt it will go that high. http://yhoo.it/16uRDi7;c=
    2 Apr 2013, 10:16 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs